Cytosine arabinoside (ARA C), a competitive inhibitor of the incorporation of P'-deoxycytidine into DNA in other cell types, caused a concentration-dependent inhibition of KCI-and insulin-stimulated survival of postmitotic ciliary parasympathetic ganglion neurons, and the nerve growth factor (NGF)-stimulated survival of postmitotic dorsal root ganglion (DRG) sensory neurons in vitro. The IC,, for survival was 2 x 1O-8 M for both types of neurons after 4 d under the culture conditions used. The inhibition of DRG survival by ARA C in the presence of varying concentrations of NGF indicated that ARA C acted as an apparent noncompetitive antagonist of NGF. This cytotoxic effect of ARA C was blocked by 2'-deoxycytidine, but not by cytosine, 2'-deoxyadenosine, 2'-deoxyguanosine, or 2'-deoxythymine, indicating that ARA C was interfering with a deoxycytidine-specific survival process. Cytidine could block ARA C toxicity, but it was 40 times less potent than 2'-deoxycytidine.
The blockade of the cytotoxic effect of ARA C by L'-deoxycytidine indicated that P'-deoxycytidine was an apparent competitive antagonist of ARA C toxicity. 2'-Deoxycytidine, by itself, was not survivalpromoting.
Other antimitotic agents, such as adenine arabinoside, thymine arabinoside, Sfluorodeoxyuridine, S-bromodeoxycytidine, 5-azadeoxycytidine, and aphidicolin had no effect on neuronal survival at a concentration 5000 times the EC,, of ARA C, indicating that inhibition of DNA synthesis or repair was probably not the mechanism by which ARA C inhibited neuronal survival and that other P'-deoxynucleosides were not involved in the survival-promoting process. Nitrobenzylthioinosine, an inhibitor of 2'-deoxycytidine and ARA C membrane transport in other cell types, inhibited the cytotoxic effect of ARA C in neurons, suggesting that ARA C entered the neurons through a similar transport mechanism and that ARA C needed to gain access to the inside of the neuron to be effective. These results indicate that ARA C, in addition to being an antimitotic agent for dividing cells, is also cytotoxic for postmitotic neurons. This inhibition of neuronal survival by ARA C is hypothesized to be due to inhibition of a 2'-deoxycytidine-dependent process that is Neuronal survival depends upon extracellular neurotrophic factors derived from target tissues, and many such factors are believed to exist, each directed toward a specific neuronal type or several types. Nerve growth factor (NGF) has been shown to be important in vivo for the differentiation and survival of sympathetic, dorsal root ganglion (DRG) sensory, and probably certain CNS cholinergic neurons (Levi-Montalcini and Angeletti, 1968; Johnson et al., 1980; Hefti et al., 1985) . A number of other factors have been highly purified and shown to have survival-promoting effects on specific neuronal types in vitro (Barde et al., 1982; Barbin et al., 1984; Morrison et al., 1986; Wallace and Johnson, 1987) . The molecular mechanism by which these factors, even the well-studied NGF, maintain the survival of neurons is not understood, but it is possible that a number of different neurotrophic factors share common intracellular mediators. A number of substances have been identified that may have a role in neuronal survival and include the Na+,K+ pump (Skaper et al., 1986 ) protein kinase C (Montz et al., 1985) methyltransferase (Acheson et al., 1986) CAMP (Rydel and Greene, 1988) and ras p21 (Hagag et al., 1986) . We report in this paper data suggesting that 2'-deoxycytidine, in contrast to other 2'-deoxynucleosides, may be a critical factor in the survival of postmitotic peripheral neurons and that this involvement appears to be independent of DNA synthesis or repair. Cytosine arabinoside (ARA C), which is a structural analog of 2'-deoxycytidine, had potent cytotoxic effects on parasympathetic and DRG sensory neurons, whereas other antimetabolite DNA synthesis inhibitors had no effect on neuronal survival at SOOO-fold higher concentrations. ARA C differs from 2'-deoxycytidine by having an arabinose sugar in place of the 2'-deoxyribose sugar. This indicates that 2'-deoxycytidine is important in neuronal survival and that its role in cellular function may extend beyond that of a metabolic precursor of DNA.
Materials and Methods
Materials. Insulin was a gift of Eli Lilly Co. (Indianapolis, IN). Eagle's minimum essential medium (MEM), fetal calf serum, and trypsin were purchased from Gibco (Grand Island, NY). Collagenase (type 4) was purchased from Cooper Biomedical (Malvem, PA). NGF (2%) was prepared by the method of Bocchini and Angeletti (1969) . All other reagents were purchased from Sigma Chemical Co. (St. Louis).
Methods. Parasympathetic ciliary or DRG were taken from chicken chickens (Rohrer and Thoenen, 1987) . E8 neurons were used because very few non-neuronal cells were obtained upon plating at this age, even in the absence of antimitotic agents. Ciliary ganglia were digested by a 30 min incubation at 37°C in trypsin (0.0 125%), and DRG were digested by a 20 min incubation at 37°C with collagenase (type 4) followed by a 10 min incubation at 37°C with trvnsin (0.0625%). Ganglia were dissociated into single cells by trituration with' a small-bore piiet. Neurons were incubated at 37°C in 0.35 ml of medium on a double layer of air-dried, rat tail collagen in 48 well plastic dishes (Costar 3548) in 95% air, 5% CO>. The medium included Eagle's MEM, 100 units/ml of penicillin, 100 &ml of streptomycin, and 10% fetal calf serum. Insulin served as the trophic factor for ciliary neurons and NGF for DRG neurons. KC1 (35 mM) was also included in the ciliary neuron medium. Plating efficiency, determined 2 hr after adding the neurons to the wells, was usually about 70%. Ciliarv and DRG neurons were cultured for 4 d at 37°C and then evaluated for survival. Neurons were fixed in 2% glutaraldehyde in PBS, and the mean number of surviving neurons was determined in 15 fields using an inverted microscope with a phase-contrast objective (Barbin et al., 1984) . Neurons could easily be distinguished from non-neurons in these cultures. Viable neurons were round and phase bright, whereas dead neurons were crenated and phase dark. Survival was expressed as the mean number of surviving neurons per well.
Berg (198 1). In the presence of 35 mM KCl, insulin caused a logarithmic increase in survival up to 500 mU insulin/ml, representing a 3.5-fold increase at the highest concentration. By contrast, a 25,000 x g supernatant fraction of pig lung caused an 8-fold increase in neuronal survival in the same experiment. We have previously reported pig lung to contain high concentrations of parasympathetic neurotrophic activity Johnson, 1986, 1987) . With insulin, maximal survival was apparently not achieved, even at the highest concentration of insulin used (500 mu/ml; 6.5 x 1O-6 M). Insulin caused the outgrowth of neurites from some ciliary neurons, but this was not characterized further. Insulin at a concentration of 50 mu/ml, which gives a 3-fold stimulation of survival, was used as the trophic factor to maintain survival of neurons in further experiments using ciliary neurons. The actual importance of insulin as an in vivo neurotrophic factor for parasympathetic neurons is questionable because of its relatively low concentration in the blood compared with the concentration needed to see significant neuronal survival. It was simply used here as a purified survival-promoting factor for further studies on the role of 2'-deoxycytidine in the survival of ciliary neurons.
Results
Efect of insulin on the survival of parasympathetic neurons The rationale for the experiments presented in this paper is based on a serendipitous initial finding. Experiments were being performed in which various cell types were being grown in a defined, serum-free medium (HB 10 1; Hana Biologicals, Inc.). The conditioned medium from these cells was being tested for survival-promoting activity on ciliary neurons incubated in a medium that would not support neuronal survival. The ciliary neuron medium contained Eagle's MEM, 10% serum, antibiotits, KC1 (35 mM), and ARA C (1 O-5 M). The ARA C was routinely added with the rationale of killing non-neuronal cells that could confuse a search for neurotrophic activity. We observed, unexpectedly, that HBlOl medium alone (not conditioned) possessed survival-promoting activity. HB 10 1 medium is composed of RPM1 1640, NCTC (a supplement containing amino acids, vitamins, cofactors, antioxidants, and 2'-deoxynucleosides), and 3 proteins (insulin, transferrin, and BSA). In order to determine which of the components had survival-promoting activity, systematic experiments were performed to determine which component(s) had the ability to maintain the survival of E8 chicken ciliary neurons in vitro under these conditions. Two components were found to maintain survival: 2'-deoxycytidine and insulin. The 2'-deoxycytidine in the HB 10 1 medium was found to act by blocking the cytotoxic effect of ARA C present in the ciliary neuron medium and is presented in further sections, whereas insulin was found to directly stimulate neuronal survival. Insulin-stimulated survival of neurons has been reported previously (Bottenstein et al., 1980; Collins and Dawson, 1983; Skaper et al., 1984 ). An initial experiment was performed to determine the range of effective concentrations of the insulin and is presented in Figure 1 . Ciliary neurons were cultured in Eagle's MEM containing 10% serum, 35 mM KCl, and antibiotics as described in Materials and Methods. When the ciliary neurons were cultured in the presence of 35 mM KCl, but in the absence of ARA C and insulin, there was a basal level of survival after 4 d, represented by the zero concentration point (Fig. 1) . The ability of KC1 to support the survival of ciliary neurons is a phenomenon that has been reported previously by Nishi and Concentration-response effect of ARA C on the survival of parasympathetic neurons As previously discussed, 2'-deoxycytidine was one of the components of the HBlO 1 medium that had survival-promoting effects on ciliary neurons under the culture conditions used, which included KC1 (35 mM) and ARA C (10m5 M). Normally, it would be predicted that ARA C (and other agents that inhibit DNA synthesis) would not exert deleterious effects on postmitotic neurons. An experiment investigating the concentrationresponse effect of ARA C on survival of ciliary neurons was performed in which E8 chicken ciliary neurons were incubated for 4 d in the presence of varying concentrations of ARA C (Fig.  2) . Survival was maintained with either KC1 (35 mM) or KC1 plus insulin (50 mu/ml). To determine the number of surviving neurons, the neurons were fixed in glutaraldehyde and counted as described in Materials and Methods. The results showed that ARA C caused a concentration-dependent decrease in neuronal survival and that it was very potent. Fifty percent inhibition (IC,,) was observed at 2 x lo-* M when the neurons were incubated in either KC1 or KC1 plus insulin. Thus, the ciliary neurons were very sensitive to low concentrations of ARA C in the presence of both agents, KC1 and insulin Concentration-response relationship of the cytotoxic effect of ARA C on DRG neurons and its blockade by 2'-deoxycytidine For the purpose of determining whether ARA C is toxic for another neuronal type that is dependent on a different trophic factor, a similar experiment was carried out using E8 chicken DRG neurons that were cultured with purified 2.5s mouse NGF (10 r&ml). DRG neurons were incubated with NGF for 4 d with varying concentrations of ARA C (10-9-10-4 M) in the absence or presence of 2'-deoxycytidine (1 Od4 M) and then evaluated for survival as described in Materials and Methods. The results showed that ARA C caused a concentration-dependent inhibition of DRG neuron survival with an IC,, = 2 x lo-* M (Fig. 3 ), indicating that, like ciliary neurons, DRG neurons were very sensitive to ARA C. It should be noted, however, that we have observed that the concentration dependence of ARA C toxicity can vary with culture conditions. In particular, it would appear that the variable amount of 2'-deoxycytidine in sera will affect the apparent toxicity of ARA C. Although the concentration of 2'-deoxycytidine in the serum was not measured, 2'-deoxycytidine is present at concentrations of 0.5-4.0 x 10m6 M in human plasma (Danhauser and Rustum, 1980) . The cytotoxic effect of ARA C on the DRG neurons was blocked by 2'-deoxycytidine, suggesting that survival of DRG neurons may also normally be dependent on 2'-deoxycytidine or on a 2'-deoxycytidine-dependent process. Similar results were obtained with ciliary neurons (data not shown). In addition, the cytotoxic effect of ARA C on the non-neuronal cells that were present was also reversed by 2'-deoxycytidine. Thus, ARA C kills both ciliary and DRG neurons in a 2'-deoxycytidine-reversible manner, suggesting that there may be a survival pathway common to both neuronal types, even though the trophic factors used to maintain the survival of these neurons were different.
Efect of 2'-deoxycytidine on the survival of ciliary and DRG neurons The ability of 2'-deoxycytidine to prevent the neurotoxic effects of ARA C led to the question of whether 2'-deoxycytidine by itself had survival-promoting effects on ciliary or DRG neurons. E8 ciliary or DRG neurons were incubated for 4 d in the presence of 2'-deoxycytidine (1 Om3 M) in serum-containing medium and then evaluated for survival. NGF (100 n&ml) and a 25,000 x g pig lung supernatant fraction were used as positive controls for DRG and ciliary neurons, respectively. The results showed that 2'-deoxycytidine had no survival-promoting effects on either ciliary or DRG neurons, whereas NGF maintained the survival of DRG neurons and pig lung supernatant fraction maintained the survival of ciliary neurons (Table 1) . Furthermore, 2'-deoxycytidine had no survival-promoting effect on ciliary neurons cultured in serum-free medium (data not shown).
Ability of 2'-deoxycytidine and its nucleotides, cytidine, cytosine, or other 2'-deoxynucleosides to block the cytotoxic efect of ARA C on ciliary and DRG neurons It was of interest to determine if 2'-deoxycytidine nucleotides, metabolic precursors of 2'-deoxycytidine, or other 2'-deoxynucleosides could substitute for 2'-deoxycytidine, because of their close structural similarity to 2'-deoxycytidine. 2'-Deoxycytidine nucleotides contain mono-, di-, or triphosphate groups, and it is the triphosphate form that is the substrate for DNA Dissociated ES chicken ciliary or DRG neurons were incubated for 4 d with 2'-deoxycytidine (10-l M), 2.5s mouse NGF (100 @ml), or a 25,000 x gsupernatant fraction of pig lung (1 mg/ml). The neurons were then fixed in glutaraldehyde and counted. 2.2 ganglion equivalents of ciliary neurons and 2.25 ganglion equivalents of DRG neurons were plated per well. Values represent the means f SE of 4 replicates. N.D. = not determined in this experiment.
NGF has been previously shown not to be survival-promoting for ciliary neurons and the pig lung neurotrophic factor (NTF) has been previously shown not to be survival-promoting for DRG neurons Johnson, 1986, 1987 (Lehninger, 1982) . Cytidine and cytosine are normally precursors in the formation of 2'-deoxycytidine; cytidine differs from 2'-deoxycytidine by having a hydroxyl group at position 2 in the ribose ring, and cytosine differs from 2'-deoxycytidine by not having the ribose ring (Lehninger, 1982) . The other 2'-deoxynucleosides differ from 2'-deoxycytidine by having a purine ring (2'-deoxyadenosine and 2'-deoxyguanosine) instead of a pyrimidine ring or having a different pyrimidine ring (2'-deoxythymine). E8 ciliary neurons were incubated with insulin (50 mu/ml), or DRG neurons of the same age were incubated with NGF (10 r&ml), and ARA C (1 Om4 M) was added to both neuronal types for 4 d in the presence of the various agents present at an equimolar concentration (1 Om4 M). The results showed that not only 2'-deoxycytidine, but also its nucleotides, blocked the cytotoxic effect of 1 O-4 M ARA C on DRG neurons (Fig. 4) , whereas the other 2'-deoxynucleosides, cytosine, or cytidine could not. Virtually identical results were obtained with ciliary neurons (data not shown). It is possible that the 2'-deoxycytidine nucleotides were dephosphorylated to 2'-deoxycytidine or that 2'-deoxycytidine was phosphorylated to a 2'-deoxycytidine nucleotide.
Ability of varying nucleoside concentrations to block ARA C-induced death of DRG neurons The previous experiment demonstrated that an equimolar concentration (1 O-4 M) of either cytidine, 2'-deoxyadenosine, 2'-deoxyguanosine, or 2'-deoxythymine could not block DRG neuron death caused by an equimolar concentration (lo-" M) of ARA C. An experiment was next performed to determine if any of those chemicals could block ARA C-induced neuron death when they were given in concentrations lo-to loo-fold higher than ARA C. In this experiment all neurons were incubated with 10 ng NGF/ml. ARA C, 1O-5 M, was given to inhibit survival, and varying concentrations of 2'-deoxycytidine, cytidine, or other 2'-deoxynucleosides were added to determine if they would block ARA C. The results of this experiment (Fig. 5) showed that high concentrations of cytidine could block ARA C, but that high concentrations of 2'-deoxynucleosides other than 2'-deoxycytidine could not. The EC,,s were 2.5 x 10m6 M for 2'-deoxycytidine and 1 x 1O-4 M for cytidine, whereas 10m3 M of either 2'-deoxyadenosine, 2'-deoxyguanosine, or 2'-deoxy- thymine could not block ARA C (1 O-5 M). This indicates that 2'-deoxycytidine was about 40-fold more potent than cytidine, but it is possible that cytidine was converted to 2'-deoxycytidine for it to be effective. In fact, ribonucleotides (i.e., CDP) are normally the precursors of deoxyribonucleotides (i.e., dCDP) in other cell types (Lehninger, 1982) . These results suggest that the mechanism by which ARA C inhibits neuronal survival is through a process that preferentially utilizes 2'-deoxycytidine. The different E&s for 2'-deoxycytidine (Fig. 5 ) and ARA C (Figs. 2 and 3 ) may be the result of different amounts of membrane transport, metabolism, affinity for intracellular 2'-deoxycytidine-dependent pathways, or possibly phosphorylation.
Effect of antimitotic agents on the survival of parasympathetic and DRG neurons A number of antimitotic agents which act by inhibiting DNA synthesis but whose mechanism of action does not involve competition with 2'-deoxycytidine were examined for their possible cytotoxic effect on ciliary and DRG neurons. These agents included adenine arabinoside (ARA A), thymine arabinoside (ARA T), 5fluorodeoxyuridine + uridine (FUDR), and aphidicolin. ARA A, ARA T, and FUDR act by interfering with the incorporation of 2'-deoxynucleotide into DNA, whereas aphidicolin is an inhibitor of DNA polymerase LY (Huberman, 1981) . Also, 5-bromodeoxycytidine and 5-azadeoxycytidine, which both cause hypomethylation of cytosine groups of DNA (Pinedo and Chabner, 1985) , were tried. ARA C was used as the control. E8 ciliary neurons were incubated with insulin (50 mu/ml), and E8 DRG neurons were incubated with NGF (10 @ml) for 4 d in the presence of various antimitotics present at 1O-4 M and were then evaluated for survival as described. The results showed that no inhibitor of DNA synthesis other than ARA C had a cytotoxic effect on DRG neurons (Fig. 6) . Identical results were obtained with ciliary neurons (data not shown). Thus, other antimitotic agents, present at a 5000-fold greater concentration (1 x 1O-4 M) than the IC,, of ARA C (2 x 1O-8 M; Figs. 2 and 3) were not cytotoxic.
Efect of a deoxynucleoside membrane transport inhibitor, nitrobenzylthioinosine, on the cytotoxic efect of ARA C Nucleosides, deoxynucleosides, and ARA C gain access to the interior of cells by nonconcentrative, reversible facilitated diffusion through a membrane transporter that has been characterized in a number of cell types (Plagemann et al., 1978; Wiley et al., 1982; Young and Jarvis, 1983) , although not in neurons. Nitrobenzylthioinosine (NBTI) is a specific inhibitor of transport of these compounds (Wiley et al., 1982; Young and Jarvis, 1983) into cells. The possibility that ARA C was gaining intracellular access to ciliary and DRG neurons via this transporter was examined by determining if NBTI could block the cytotoxic effect of ARA C. E8 ciliary or DRG neurons were incubated with insulin (50 mu/ml) or NGF (10 @ml), respectively, and either NBTI alone (1 Om4 M) or NBTI + ARA C (1 O-4 M) for 4 d and then evaluated for survival. The results showed that NBTI blocked the cytotoxic effect of ARA C on DRG (Fig. 6) shown). This suggests that ARA C enters the neuron via a NBTIsensitive membrane transporter such as those that have been found in other cell types. This experiment also showed that NBTI, by itself, was not toxic to the neurons.
Efect of NGF on ARA C-induced inhibition of DRG neuron survival Previous experiments demonstrated the inhibition by ARA C of DRG neuron survival in the presence of one concentration of NGF (10 r&ml). An experiment was performed to determine the concentration dependence of the survival-promoting effect of varying concentrations of NGF in the presence of one concentration of ARA C. E8 DRG neurons were incubated with no NGF or 1, 10, 100, or 1000 rig/ml NGF in the absence or presence of 1O-6 or 1O-5 M ARA C for 4 d and then evaluated for survival. The results showed that ARA C was cytotoxic at all concentrations of NGF (Fig.7) . High concentrations of NGF could not completely overcome the cytotoxic effects of ARA C, suggesting that NGF and ARA C were not directly competing with each other. This demonstrates that ARA C decreases the efficacy of NGF and, thus, that it is functionally a noncompetitive antagonist since increasing NGF concentrations only partially overcame the effects of ARA C. These results contrast with those demonstrating that ARA C is a competitive antagonist of 2'-deoxycytidine (Fig. 5) since 2'-deoxycytidine can completely overcome the cytotoxic effects of ARA C. Discussion ARA C is an antimitotic and cancer chemotherapeutic drug that is a structural analog and competitive inhibitor of 2'-deoxycytidine in cells capable of mitosis. In the experiments presented in this paper, it was found to inhibit in a concentration-dependent manner the survival of postmitotic parasympathetic and DRG neurons in vitro. Several other studies have reported that ARA C is toxic to neurons in vitro (Bustos et al., 1980; Oorschot and Jones, 1986; Smith and Orr, 1987) . However, the greater implication that 2'-deoxycytidine may have an important role in neuronal survival has not been previously considered. It is probable that this cytotoxic effect of ARA C on neurons was not the result of a general toxic effect, such as membrane perturbation, for a number of reasons. Under the culture conditions used here, the cytotoxic effect of ARA C on neurons was potent, with an IC,, = 2 x 10m8 M on both neuronal types and could be blocked by 2'-deoxycytidine and its deoxynucleotides, but not by a number of structurally related compounds that included cytosine, or other 2'-deoxynucleosides. An important experiment ruled out the possibility that 2'-deoxycytidine might be blocking the toxic effect of ARA C on neurons by stimulating the few non-neuronal cells that were present: When 2'-deoxycytidine was added to cultures containing neurons and nonneuronals (but no trophic agent or ARA C), there was no increase in survival compared with cultures without 2'-deoxycytidine, trophic agent, or ARA C. Thus, it is unlikely that 2'-deoxycytidine indirectly blocks the cytotoxic effect of ARA C on neurons by stimulating non-neuronals to condition the medium, i.e., to make neurotrophic factors.
The blockade by 2'-deoxycytidine of ARA C-induced neuronal death could be taking place at several sites. 2'-Deoxycytidine may block ARA C at an intracellular site, one involved in the regulation of neuronal survival. Alternatively, 2'-deoxycytidine may block ARA C at a membrane transporter that is specific for 2'-deoxycytidine and ARA C, one that is not blocked by at least a loo-fold higher concentration of other 2'-deoxynucleosides. However, it is generally considered, at least in other cell types (neurons have not been examined), that there is not a specific transporter for 2'-deoxycytidine and ARA C, but rather that there is one common transporter with low specificity for all nucleosides and deoxynucleosides (Cohen et al., 1979; Paterson et al., 1979) . The ability of NBTI to prevent ARA C toxicity indicates that neurons accumulate deoxynucleosides in a manner similar to other cell types. Last, 2'-deoxycytidine may block ARA C by competing with it for intracellular phosphorylation (Balzarini et al., 1987) .
As mentioned above, ARA C neurotoxicity was blocked in these neurons by a specific inhibitor ofthe nucleoside membrane transporter, nitrobenzylthioinosine. This indicates that ARA C needed to gain access intracellularly for it to be effective. On the other hand, it was found that NBTI by itself was not toxic to the neurons. This suggests that, if 2'-deoxycytidine is important for neuronal survival, the source of the 2'-deoxycytidine was not the culture medium, since NBTI would normally be expected to block the membrane transport of 2'-deoxycytidine from the medium into the neurons. This implies that neurons may synthesize 2'-deoxycytidine intracellularly, as do other cell types.
Other antimitotic agents with structural similarity-including ARA A, ARA T, FUDR, A-dC, and B-dC-were not cytotoxic to the neurons. In addition, an antimitotic agent that is not structurally related to ARA C, aphidicolin, was not cytotoxic. These findings indicate that inhibition of DNA synthesis or repair was not the mechanism by which ARA C inhibited neuronal survival since these other agents are DNA synthesis and/ or repair inhibitors (Friedberg, 1985) yet had no effect on neuronal survival. They also suggest that other 2'-deoxynucleosides, including 2'-deoxyadenosine or 2'-deoxythymine, are not critical for neuronal survival, since there was no inhibition of survival by ARA A, ARA T, or FUDR. Further, they show that the ability of ARA C to kill the neurons was not due to a toxic effect of the arabinoside ring, since both ARA A and ARA T also contain arabinoside but were without any effect on neuronal survival. Last, the results show that a change in the cytosine ring, as in 5bromodeoxycytidine
and 5-azadeoxycytidine, as opposed to an alteration of the ribose ring, as in ARA C, was not sufficient to allow these agents to be cytotoxic. This provides further evidence for the specificity of the adverse effects of ARA C on neuronal survival. Thus, these data very strongly suggest that ARA C inhibits survival of parasympathetic and DRG neurons by interfering with an intracellular 2'-deoxycytidinespecific process that is independent of DNA synthesis or repair.
Whereas ARA C inhibited neuronal survival by a mechanism that was reversible by 2'-deoxycytidine, 2'-deoxycytidine by itself in the absence of trophic factor (i.e., NGF) under these culture conditions was not a survival-promoting factor. One possible explanation for this is that 2'-deoxycytidine may be necessary but not sufficient for neuronal survival. Survival may be dependent simultaneously on several critical intracellular molecules, one of which may be 2'-deoxycytidine.
ARA C killed neurons that could normally be maintained in vitro by several different trophic factors. Both KC1 -and insulinstimulated survival of parasympathetic neurons and NGF-stimulated survival of DRG neurons were inhibited by ARA C. Inhibition of survival was seen not only if the neurons were plated in ARA C, but also if ARA C was added after the neurons had become established in culture for a week (data not shown). It has also been found that ARA C can inhibit survival of ciliary neurons whose survival could normally be maintained in vitro by a parasympathetic factor from pig lung Johnson, 1986, 1987) and survival of rat sympathetic neurons normally maintained by NGF (data not shown). This suggests that a 2'-deoxycytidine-dependent process may be a common mediator of the survival-promoting effects of several trophic factors on peripheral neurons or that 2'-deoxycytidine takes part in a general survival pathway common to these neurons but one that may not be directly linked to trophic factor action. Then, one may speculate that alteration of levels of 2'-deoxycytidine could conceivably be a factor in neuronal death in vivo.
ARA C is used clinically as a cancer chemotherapeutic drug to treat leukemia. Notable among its side effects is CNS toxicity, which has been seen mostly as cerebral and cerebellar damage (Lazarus et al., 198 1; Winkelman and Hines, 1983; Benger et al., 1985; Hwang et al., 1985) . The incidence of cerebellar toxicity has been shown to increase with the dose of ARA C and the age of the patient (Herzig et al., 1987a, b) . Postmortem examination has revealed loss of Purkinje cells (Winkelman and Hines, 1983) . Peripheral sensory neuropathy, seen as parasthesis, has also been reported in a small number of patients (Russell and Powles, 1974; Scherokman et al., 1985) . Autonomic dysfunction has not been reported, but it is possible that such changes would be subtle compared with the more prominent side effects of ARA C, and the effects of cancer. Thus, based on these reports, there is some evidence to suggest that 2'-deoxycytidine may also have an important role in the survival of certain neurons in vivo.
Interestingly, another structurally related drug, 2',3'-dideoxycytidine, has also been shown to cause neurotoxicity. 2',3'-Dideoxycytidine has been shown to be the most potent agent in the class of nucleoside analogs for inhibition of the cytopathic effect of the human immunodeficiency virus (HIV), the etiologic agent ofacquired immunodeficiency syndrome (AIDS) (Mitsuya et al., 1987) . Phase I clinical trials have reported that 2',3'-dideoxycytidine caused a peripheral sensory neuropathy in 50% of treated patients and that it appeared to be dose dependent and due to axonal degeneration (Yarchaon et al., 1988) . Preliminary experiments in our laboratory have shown that 2',3'-dideoxycytidine kills dorsal root sensory neurons in vitro and that this could be blocked by 2'-deoxycytidine (T. L. Wallace, unpublished observations). We are currently carrying out a full characterization of this in vitro observation, which may help explain the clinical neuropathic effects of this AIDS drug.
There are at least 3 possible ways in which ARA C could inhibit the survival of neurons by blocking a 2'-deoxycytidinedependent specific pathway. These include (1) inhibition of DNA synthesis , (2) inhibition of DNA repair (Fram and Kufe, 1985) , or (3) inhibition of a non-DNA, 2'-deoxycytidine-dependent process. Postmitotic neurons, which were used in this study, do not undergo DNA synthesis for cell and Johnson * Deoxycytidine-Dependent Neuronal Survival replication. Therefore, the mechanism by which ARA C inhibits neuronal survival is not by inhibition of DNA synthesis. In fact, our work has shown that parasympathetic and DRG neurons are not sensitive to high concentrations of a number of inhibitors of DNA synthesis, except for ARA C. The possibility remains that the other antimitotics were not transported into the neurons, but such selective transport would be unlike any other cell type and would seem very unlikely. In fact, we have previously shown that a much lower concentration (1 O-5 M) of aphidicolin completely inhibits viral DNA synthesis in neurons (Wilcox and Johnson, 1988) indicating that aphidicolin can get into the neuron. It is also possible that ARA C could inhibit neuronal survival by interfering with DNA repair since ARA C can inhibit DNA repair in other cell types (Fram and Kufe, 1985; Friedberg, 1985) . However, it would again be difficult to explain why the other antimitotics tested (i.e., aphidicolin) had no effect on survival. Aphidicolin has also been shown to inhibit DNA repair (Berger et al., 1979) yet did not inhibit neuronal survival. There is some evidence that ARA C can alter other cellular functions. ARA C has been shown to inhibit glycoprotein and glycolipid synthesis by blocking incorporation of galactose, N-acetylglucosamine, and sialic acid from their nucleotide carriers in hamster embryo fibroblasts (Hawtrey et al., 1973 (Hawtrey et al., , 1974 . ARA C inhibited de nova sialic acid synthesis and membrane resialylation in HL-60 leukemia cells (Hindenburg et al., 1985) and has been reported to be a competitive inhibitor of sialic acid synthetase (Myers-Robfogel and Spataro, 1980) and of sialyltransferase (Klohs et al., 1979; Myers-Robfogel and Spataro, 1980) . Several other studies have suggested that the cytotoxic effect of ARA C may involve the activation of certain cellular systems. Cycloheximide, an inhibitor of protein synthesis, has been shown to protect against the cytotoxic effect of ARA C on intestinal epithelial (Lieberman et al., 1970) and bone marrow cells (Ben-Ishay and Farber, 1975) in vitro. This suggests that cell death due to ARA C is not a process of mere passive attrition, but may require the active synthesis of specific proteins. We have recently tested this hypothesis using neonatal rat sympathetic neurons, and we found that RNA and protein synthesis inhibitors blocked ARA C-induced neuronal death (Wallace et al., 1988) . This is similar to the finding that RNA and protein synthesis inhibitors also block death of sympathetic neurons due to NGF deprivation and suggests that a similar "death program" may occur in both conditions.
A number of studies have also shown that ARA C in nonlethal concentrations can exert a variety of actions through differential alteration ofgene expression. In human U-937 cells, it increases levels of c-fos and decreases levels of c-myc but does not change the expression of actin or c-fms (Mitchell et al., 1986) . In K562 cells, ARA C causes increased heme synthesis, accumulation of a,~, E, and <-globin RNA, and enhanced cell surface expression of glycophorin (Watanabe et al., 1985) . In the embryonic chick retina, ARA C increases the levels ofglutamine synthetase (Ones and Moscona, 1974) . Last, it has also been reported that ARA C can cause the differentiation of cells (Griffin et al., 1982; Takeda et al., 1982) . Thus, ARA C may have a complex effect on cellular function. It is probable that ARA C exerts many of these effects by competing with 2'-deoxycytidine for incorporation into DNA, but it is also possible, based on work presented in this paper, that ARA C could be exerting some of its actions by competing with 2'-deoxycytidine at other sites.
Interestingly, it has been shown that 2 pools of dCTP exist in cells capable of mitosis (Mordoh and Fridlender, 1977; Nicander and Reichard, 1985) , suggesting that it can be utilized in several different ways. One dCTP pool is used preferentially for DNA synthesis (Spyrou and Reichard, 1987) whereas the other is used for synthesis of deoxycytidine adducts, such as dCDP-diglyceride (Ter Schegget et al., 197 l) , dCMP-phosphatidic acid (Medrano and Mordoh, 1979) , and dCDP-choline and dCDP-ethanolamine (Sugino, 1957; Potter and Buettner-Janusch, 1958; Spyrou and Reichard, 1987) . These deoxycytidine adducts have been found to substitute effectively for cytidine adducts (Lehninger, 1982) as intermediates in the formation of phospholipids (Kennedy et al., 1959; Ter Schegget et al., 1971) . Substitution of a false substrate, such as ARA C, for 2'-deoxycytidine may block this pathway. ARA C has been shown to inhibit the formation of phosphatidyl-dCMP in mouse thymocytes (Iujvidin et al., 1983) . ARA C has also been shown to form ARA C diphosphate choline in normal and neoplastic cells (Lauzon et al., 1978a, b) . We speculate that the formation of deoxyliponucleotides in postmitotic neurons may be critical for neuronal survival and that ARA C acts to inhibit neuronal survival by competing with 2'-deoxycytidine in this synthetic pathway.
